It seems a bit strange that they might approve this technology on people before a simmilar approach is approved to control beetle larvae feeding on corn roots.
the fear that has paralyzed the world for most of the last year has to end. If that means a less than fully tested marginally effective vaccine then so be it, as long as the sheep think it'll help them. We don't have time for the usual FDA approach of slow walking years of testing before approval, our economy will be destroyed before that happens. A reasonable assurance of safety based upon the clinical trials already done is good enough.
I won't be the first to take it but once I'm convinced there aren't any serious side effects I'll take it.
Fear is encouraging a lot of stupid behavior lately. Pandering to make it stop please is only encouraging more. Not saying this new approach is safe or not but I believe that it assumes the tiny piece of RNA they are inducing an immune response to isn't found anywhere but this virus... Heck the same fragment could be in pork or barley.
I don't want to be pedantic, but knowing some detail can be useful here.
The mRNA is not what induces the immune response. The mRNA when taken up by the cell causes the cell to produce proteins. The mRNA is from SARS-CoV-2. It causes the cell to create proteins(antigens) from the virus with out infecting you and these are what cause the immune response. Old vaccines would inject these directly, but with these new vaccines the idea is to cause your body to do what used to be done in a chicken egg - grow virus protein. It's kind of infecting ourcells, but with out a fully functional virus. Just bits and pieces of the virus.
When you eat pork all the DNA and RNA in the pork muscle cells are digested. No worries there.
A major hurdle with these vaccines is to develop a delivery mechanism to get the DNA or mRNA into the cell and getting itto stay stable long enough to cause protein creation in quantities large enough to obtain an immune response. Not positive but these delivery mechanisms are where the companies distinguish themselves with patents.
